Analyst Ratings for Agomab Therapeutics (AGMB)
AGMB Rating Summary
AGMB Price Target Summary
- Highest: $36.00 (Leerink)
- Lowest: $28.00 (Morgan Stanley)
- Average: $32.75
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$32.75 (+149%)
* Over Last 12-Mos
Rating Score: 10 / 10
Avg. $ Target:
$32.75 (+149%)
* Over Last 12-Mos
Rating Score: 10 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/22/2026 | H.C. Wainwright | Patrick Trucchio | New Coverage | Buy (N/A) |
35.00 (N/A) |
10.98 (13.15) |
19.76% | Details |
| 3/3/2026 | Leerink | N/A | New Coverage | Outperform (N/A) |
36.00 (N/A) |
16.21 (13.15) |
-18.88% | Details |
 |
||||||||
|
||||||||
